Angiodynamics (ANGO) EBITDA Margin (2010 - 2026)
Angiodynamics (ANGO) posted EBITDA Margin of 11.77% for Q2 2026, up 28.72% on a QoQ basis from 16.51% in Q1 2026, and down 455.0% year-over-year from 3.32% in Q2 2025.
Angiodynamics (ANGO) EBITDA Margin (2010 - 2026) Analysis & Trends
Angiodynamics' EBITDA Margin history runs 17 years deep, the most recent figure standing at 11.77% for Q2 2026.
- Quarterly EBITDA Margin fell 455.0% year-over-year to 11.77% in Q2 2026, while the trailing twelve-month figure through May 2026 was 12.47% (up 119.0% YoY) and the FY2026 annual result came in at 12.47%, up 119.0% from the prior year.
- EBITDA Margin was 11.77% for Q2 2026 at Angiodynamics, up from 16.51% in the prior quarter.
- Across five years, EBITDA Margin topped out at 44.52% in Q3 2023 and bottomed at 265.88% in Q1 2024.
- A 5-year average of 24.35% and a median of 13.96% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2024 — EBITDA Margin slumped 25482 bps — and 2025, when it jumped 25203 bps.
- Angiodynamics' EBITDA Margin stood at 9.5% in 2022, then slumped by 75 bps to 16.59% in 2023, then gained by 8 bps to 15.23% in 2024, then jumped by 49 bps to 7.71% in 2025, then sank by 53 bps to 11.77% in 2026.
- Business Quant data shows ANGO's EBITDA Margin at 11.77% in Q2 2026, 16.51% in Q1 2026, and 7.71% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 98.77% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 33.60% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 1.97% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.74% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 34.92% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 20.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -2.87% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.04% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 13.65% |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | -11.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -11.77% |
| Feb 28, 2026 | -16.51% |
| Nov 30, 2025 | -7.71% |
| Aug 31, 2025 | -14.07% |
| May 31, 2025 | -7.22% |
| Feb 28, 2025 | -13.85% |
| Nov 30, 2024 | -15.23% |
| Aug 31, 2024 | -19.41% |
| May 31, 2024 | -20.36% |
| Feb 29, 2024 | -265.88% |
| Nov 30, 2023 | -16.59% |
| Aug 31, 2023 | 44.52% |
| May 31, 2023 | -22.88% |
| Feb 28, 2023 | -11.06% |
| Nov 30, 2022 | -9.50% |
| Aug 31, 2022 | -16.31% |
| May 31, 2022 | -7.35% |
| Feb 28, 2022 | -7.16% |
| Nov 30, 2021 | -11.09% |
| Aug 31, 2021 | -10.52% |